Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Sambataro (CATANIA, Italy), A. Libra (CATANIA, Italy), S. Puglisi (FORLI', Italy), M. Pavone (CATANIALI', Italy), F. Pino (CATANIALI', Italy), S. Torrisi (CATANIALI', Italy), G. Sardo (CATANIALI', Italy), A. Vancheri (CATANIALI', Italy), S. Palmucci (CATANIALI', Italy), S. Tomassetti (FORLI', Italy), V. Poletti (AAHRUS, Denmark), C. Vancheri (CATANIA, Italy). Does “UIPAF” really exist?. 802

Member's Comments

No comment yet.

Related content which might interest you: To tracheostomize or not to tracheostomize? Source: Eur Respir J 2005; 26: Suppl. 49, 393s Year: 2005 Genetic variation and common diseases. Where are we? Where to go? Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008 Communication of bad news: do regional differences exist in Europe and around the world? Source: ERS Online Course 2016 Year: 2016 Whither pulmonary rehabilitation? Will alternative modes help or hurt? Source: Eur Respir J, 52 (4) 1801678; 10.1183/13993003.01678-2018 Year: 2018 Why don't patients follow the rules? Understanding the motivation behind behavioural change Source: Annual Congress 2013 –PG8 How to encourage compliance with therapy Year: 2013 Wouldn't you like to know: are tertiary lymphoid structures necessary for lung defence? Source: Eur Respir J, 57 (4) 2004352; 10.1183/13993003.04352-2020 Year: 2021 What else can you expect at www.erj.ersjournals.com? Source: Eur Respir J 2007; 29: 1-3 Year: 2007 Pathology: what do we actually want to know? Source: Annual Congress 2008 - Multidisciplinary approach in interstitial lung disease Year: 2008 What’s new in neonatology? Source: International Congress 2018 – Paediatric Year in Review Year: 2018 Getting independent: what challenges should I expect? Source: International Congress 2017 – Early Career Members session Year: 2017 What is at stake? What are the possible gains and risks? Source: Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies Year: 2005 What do they know about TB? Source: Eur Respir J 2002; 20: Suppl. 38, 163s Year: 2002 Perspective of a pulmonologist: what might we expect and what do we need to know? Source: Eur Respir Monogr 2015; 68: 261-273 Year: 2015 Does drug-induced emphysema exist? Source: Eur Respir J 2013; 42: 1464-1468 Year: 2013 What's in a name? That which we call IPF, by any other name would act the same Source: Eur Respir J, 51 (5) 1800692; 10.1183/13993003.00692-2018 Year: 2018 How to best target the hard-to-reach? The UK-experience? Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice Year: 2018